Direct Measurement of Performance: A New Era in Antimicrobial Stewardship

Direct Measurement of Performance: A New Era in Antimicrobial Stewardship

For decades, the performance of antimicrobial stewardship programs (ASPs) has been measured by incidence rates of hospital-onset <i>Clostridioides difficile</i> and other infections due to multidrug-resistant bacteria. However, these represent indirect and nonspecific ASP metrics. They a...

Full description

Bibliographic Details
Main Authors:	Majdi N. Al-Hasan, Hana Rac Winders, P. Brandon Bookstaver, Julie Ann Justo
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Series:	Antibiotics
Subjects:	Antibiotics resistance broad-spectrum agents hospital epidemiology antibiotic utilization infection control infection prevention <i>Pseudomonas aeruginosa</i> <i>Acinetobacter baumannii</i> extended-spectrum beta-lactamases carbapenem-resistant <i>Enterobacteriaceae</i> methicillin-resistant <i>Staphylococcus aureus</i>
Online Access:	https://www.mdpi.com/2079-6382/8/3/127

Similar Items

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
by: Emily M. Eichenberger, et al.
Published: (2019-04-01)

The Impact of Antimicrobial Stewardship and Infection Control Interventions on <i>Acinetobacter baumannii</i> Resistance Rates in the ICU of a Tertiary Care Center in Lebanon
by: Nesrine A. Rizk, et al.
Published: (2022-07-01)

Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study
by: Usman Abubakar, et al.
Published: (2022-12-01)

Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
by: Rachel A. Foster, et al.
Published: (2019-02-01)

Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier
by: Nejat Düzgüneş, et al.
Published: (2021-01-01)

Associations between <i>β</i>-Lactamase Types of <i>Acinetobacter baumannii</i> and Antimicrobial Resistance
by: Kristina Černiauskienė, et al.
Published: (2023-07-01)

Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review
by: Francesco Vladimiro Segala, et al.
Published: (2021-10-01)

Shifting Gears: The Future of Polymyxin Antibiotics
by: Justin R. Lenhard, et al.
Published: (2019-04-01)

Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria?
by: Eva M. Mateo, et al.
Published: (2022-09-01)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of <i>Acinetobacter baumannii</i> from the Largest Department of Internal Medicine in Slovakia
by: Yashar Jalali, et al.
Published: (2023-07-01)

Insights into the Resistome and Phylogenomics of a ST195 Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolate from the Czech Republic
by: Patrik Mlynarcik, et al.
Published: (2021-10-01)

Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?
by: Song Oh, et al.
Published: (2021-05-01)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>: A Multicenter Study in China
by: Xuemei Zhen, et al.
Published: (2020-08-01)

Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution
by: Katerina Tsilipounidaki, et al.
Published: (2022-01-01)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022-08-01)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes
by: Tomasz Bogiel, et al.
Published: (2020-12-01)

Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
by: Nicola Coppola, et al.
Published: (2022-09-01)

A 2-Year Single-Centre Audit on Antibiotic Resistance of <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> Strains from an Intensive Care Unit and Other Wards in a General Public Hospital in Greece
by: Georgios Feretzakis, et al.
Published: (2019-05-01)

In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Associated with Urinary Tract Infections in Malaysia
by: Soo Tein Ngoi, et al.
Published: (2021-02-01)

Prevalence of Carbapenem Resistance Genes among <i>Acinetobacter baumannii</i> Isolated from a Teaching Hospital in Taiwan
by: Pai-Wei Su, et al.
Published: (2023-08-01)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)

Human Body Burden of Pseudomonas aeruginosa, Antibiotics Susceptibility Pattern and Presence of Extended Spectrum β-lactamase and Carbapenemase encoding Genes in Lagos State, Nigeria
by: T. O. G. Egwuatu, et al.
Published: (2022-12-01)

Present and Future of Carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) Infections
by: Beatriz Suay-García, et al.
Published: (2019-08-01)

Antibiotic Consumption, Resistance Data, and Prevention Strategies
by: Oğuz KARABAY, et al.
Published: (2018-12-01)

Antibiotics Act with vB_AbaP_AGC01 Phage against <i>Acinetobacter baumannii</i> in Human Heat-Inactivated Plasma Blood and <i>Galleria mellonella</i> Models
by: Bartłomiej Grygorcewicz, et al.
Published: (2020-06-01)

Incidence of metallo-beta-lactamase-producing <i> Pseudomonas aeruginosa</i> in diabetes and cancer patients
by: Varaiya Ami, et al.
Published: (2008-04-01)

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
by: Helen Giamarellou, et al.
Published: (2022-07-01)

Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants
by: Ashley N. Crotteau, et al.
Published: (2023-10-01)

Editorial on the Research Topic of the Special Issue “Current Status of Acinetobacter Infections”
by: Francesca Paola Nocera, et al.
Published: (2023-01-01)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022-01-01)

First Detection of Carbapenem-Resistant <i>Escherichia fergusonii</i> Strains Harbouring Beta-Lactamase Genes from Clinical Samples
by: Tomilola Adesina, et al.
Published: (2019-09-01)

Mother-to-Neonate Transmission of Antibiotic-Resistant Bacteria: A Cross-Sectional Study
by: Lital Ashtamkar Matok, et al.
Published: (2021-06-01)

Factors Associated with Extended-Spectrum β-Lactamases and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infections: A Five-Year Retrospective Study
by: Andreas G. Tofarides, et al.
Published: (2023-10-01)

Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade
by: Ahmad Sleiman, et al.
Published: (2021-06-01)

The Study of Antibiotic Resistance and Prevalence of Extended-Spectrum Beta-Lactamase (ESBLs) Encoding Genes in Acinetobacter baumanni Isolates from Raw Foodstuffs
by: Mohammad moradi, et al.
Published: (2019-01-01)

<i>Acinetobacter baumannii</i> Bloodstream Infections: A Nationwide Study in Israel
by: Amir Nutman, et al.
Published: (2023-08-01)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

The Molecular Characterization of <i>bla</i><sub>NDM-1</sub>-Positive <i>Acinetobacter baumannii</i> Isolated in Central Greece
by: Katerina Tsilipounidaki, et al.
Published: (2023-10-01)